Qingdao Vland Biotech INC. (603739.SS)

CNY 13.0

(0.54%)

Annual Cash Flows

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Operating Cash Flow 161.36 Million 95.3 Million 89.51 Million 172.99 Million 65.32 Million 85.75 Million
Net Income 80.7 Million 85.41 Million 150.09 Million 122.3 Million 89.39 Million 92.93 Million
Depreciation & Amortization 74.28 Million 65.7 Million 51.7 Million 42.86 Million 37.83 Million 35.68 Million
Deferred income taxes -4.12 Million -1.76 Million -2.75 Million 1.9 Million -1.32 Million -473.69 Thousand
Stock-based compensation -191.25 Thousand 7.1 Million 8 Million - - -
Change in working capital -39.12 Million -79.9 Million -116.73 Million -4.44 Million -58.83 Million -48.94 Million
Other non-cash items 237.3 Million 18.74 Million -798.77 Thousand 12.27 Million -3.06 Million 6.06 Million
Investing Cash Flow -298.78 Million -428.17 Million -606.72 Million -95.73 Million -294.48 Million -70.41 Million
Investments in PPE -215.64 Million -342.02 Million -493.57 Million -211.82 Million -120.16 Million -71.56 Million
Acquisitions -10.46 Million -909.13 Thousand -45.96 Million 309.46 Thousand 110.82 Thousand 6.51 Million
Investment purchases -765.64 Million -62.2 Million -2.58 Million -1.95 Million -400 Thousand -
Sales/Maturities of investments 689.83 Million 5.25 Million 8.75 Million 5.74 Million 7.15 Million 1.14 Million
Other Investing Activities 3.13 Million -28.29 Million -73.35 Million 111.99 Million -181.18 Million 5304.36
Financing Cash Flow 150.71 Million 227.72 Million 580.55 Million -136.73 Thousand 243.11 Million -28.5 Million
Debt repayment -200.1 Million -203.69 Million -192.44 Million -179.9 Million -105 Million -123.5 Million
Dividends payments -39.76 Million -40.33 Million -36.01 Million -30.93 Million -30.93 Million -62.34 Million
Common Stock Repurchased - - 4.28 Million - 46.57 Million -
Common Stock Issuance - - -4.28 Million - -46.57 Million -
Other Financing Activities -49.39 Million 484.18 Million 810.79 Million 212.31 Million 381.01 Million 157.34 Million
Accounts receivables -36.64 Million -110.01 Million -91.02 Million -32.32 Million -42.6 Million -32.73 Million
Accounts payables 33.14 Million 51.03 Million 10.23 Million 47.55 Million -7.35 Million -4.68 Million
Inventory -35.61 Million -19.15 Million -33.18 Million -21.58 Million -7.54 Million -11.04 Million
Other working capital 29.02 Million -1.76 Million -2.75 Million 1.9 Million -1.32 Million -37.89 Million
Cash at beginning of period 213.86 Million 311.76 Million 249.88 Million 173.99 Million 159.4 Million 172.5 Million
Cash at end of period 239.59 Million 207.69 Million 311.76 Million 249.88 Million 173.99 Million 159.4 Million
Capital Expenditure -215.64 Million -342.02 Million -493.57 Million -211.82 Million -120.16 Million -71.56 Million
Effect of forex changes on cash 732.12 Thousand 1.07 Million -1.47 Million -1.22 Million 627.91 Thousand 69.81 Thousand
Net cash flow / Change in cash 25.72 Million -104.06 Million 61.87 Million 75.89 Million 14.58 Million -13.09 Million
Free Cash Flow -54.27 Million -246.71 Million -404.06 Million -38.83 Million -54.84 Million 14.18 Million

Cash Flow Charts